Radiotherapy With vs Without Chemoradiotherapy in Low-risk Nasopharyngeal Carcinoma
JAMA Associate Editor Ethan Basch, MD, gives editorial insight into a randomized clinical trial investigating the effect of radiotherapy with vs without chemoradiotherapy in patients with low-risk nasopharyngeal carcinoma. For full details, click https://ja.ma/3dN04mi and visit https://jamanetworkvideo.com/ for more content like this.
Topics discussed in this interview:
00:00 Introduction
00:38 Current Clinical Practice
01:12 Clinical Trial Summary
01:39 Findings
01:56 Is this result practice-changing?
02:34 Is this study generalizable?
03:13 Sufficiency of 10% Noninferiority Margin
03:41 Conclusion
---------------------------------------------------------------------------------
For more from JAMA
• https://www.jama.com
• https://www.facebook.com/JAMAJournal
• https://www.twitter.com/JAMA_Current
• https://www.linkedin.com/company/jama...
Follow the JAMA Network
• https://www.jamanetwork.com
• http://www.jamanetworkaudio.com
• https://www.facebook.com/JAMANetwork
• https://www.twitter.com/JAMANetwork
• https://www.instagram.com/JAMANetwork
• https://www.pinterest.com/JAMANetwork
-
Category
No comments found